Related Experiment Video
Updated: Jun 26, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Macrolactin S, a new antibacterial agent with FabG-inhibitory activity from Bacillus sp. AT28
Mi-Jin Sohn1, Chang-Ji Zheng, Won-Gon Kim
1Functional Metabolites Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Abstract:
In the course of screening for FabG inhibitors from microbial sources, a new 24-membered ring lactone named macrolactin S, along with the known compound macrolactin B, has been isolated from the mycelium of liquid fermentation cultures of Bacillus sp. AT28. The structure of macrolactin S was determined on the basis of MS and NMR data. Macrolactin S showed a dose-dependent inhibition of Staphylococcus aureus FabG, not inhibiting S. aureus FabI. Also macrolactin S inhibited the growth of S. aureus, Bacillus subtilis, and Escherichia coli.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Production of Antibiotics
Bacterial Phylum Actinobacteria
Biological Methods for Microbial Control
